LENSAR, Inc.
LNSR- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001320350
No open-market purchases or sales by LENSAR, Inc. insiders were filed in the last 90 days; 76 institutions reported holding it in 13F filings for Q2 2026, worth $25.2M in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding LENSAR, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 56 | 46 | −10 |
| Shares | 6.13M | 6.12M | −13.3K (−0.2%) |
| Value | $52.9M | $47.3M | −$5.65M (−10.7%) |
New holders (0)
Institutions that held LENSAR, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
None.
Sold out (10)
Institutions that held LENSAR, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| D. E. Shaw & Co., Inc. | 33,306 | $288.0K |
| Goldman Sachs Group Inc | 31,713 | $275.0K |
| HRT Financial LP | 13,500 | $116.0K |
| SMH Capital Advisors Inc | 11,676 | $101.0K |
| Citigroup Inc | 1,062 | $9.00K |
| New York State Common Retirement Fund | 71 | $1.00K |
| Enterprise Financial Services Corp | 122 | $1.00K |
| O'Shaughnessy Asset Management, LLC | 119 | $1.00K |
| Strategic Blueprint, LLC | 66 | $1.00K |
| Allworth Financial LP | 7 | $0 |